Highlights
- You are allowed to ask. A good clinician does not just tolerate your questions. They welcome them. These eight help you ask the right ones.
- HRT is not “one thing”. There are different hormones, doses, routes, and formulations. What is right for someone else may not be right for you.
- The headlines were wrong. The evidence around HRT has shifted significantly since 2002. The FDA removed its black-box warnings in late 2025. The conversation has moved on.
- This decision is yours. HRT is right for many more women than currently access it. These questions help you understand whether it is right for you.
You have been reading about HRT. Or someone mentioned it. Or your symptoms have reached the point where you cannot ignore them any longer.
You are not the only one sitting with this question. Most of the women we see have been here for a while, quietly wondering whether this is the right step, unsure who to ask, or not quite knowing what to ask.
That is exactly what this is for.
The consultation where you try to answer these questions can feel rushed, or like the decision has already been made before you sat down. It should not feel that way. And with the right questions in your hands, it does not have to.
Our clinical team at Menovivre is here for exactly this. We work with women navigating this moment every day. And what we know is this: you do not need to have it all figured out before you arrive. You just need the right questions. The eight below are where we would start.
Quick Answer
Why Asking the Right Questions Changes Everything
HRT is not a single drug you either take or do not take.
It is a category of treatment that encompasses different hormones, different doses, different formulations, and different routes of delivery. What is right for one woman may not be right for another. The same drug taken orally carries a different risk profile to the same drug delivered through the skin.
The right HRT for you depends on your symptom profile, your health history, and your risk factors. It is not a uniform prescription. Current clinical guidance is unambiguous on this. And that level of personalisation only comes from a real conversation.
It is also worth knowing that the evidence around HRT has shifted. Significantly. The fear that kept many women away from it for two decades was rooted in a 2002 study whose findings were misapplied to a much younger, healthier population than the one actually studied. Current guidance from the British Menopause Society and the International Menopause Society reflects a far more balanced picture. In November 2025, the US Food and Drug Administration removed the black-box warnings from estrogen-based therapies, acknowledging that the original risks had been overstated.
You are allowed to feel hopeful about this.
And whatever you are feeling right now, you do not have to navigate it alone.
Your Questions at a Glance
Question 1: Am I a Suitable Candidate for HRT?
Before anything else, this question is about you: your history, your symptoms, your body.
HRT is appropriate for most women experiencing menopausal symptoms, but the right approach depends on your specific picture. Your medical history, your family history, where you are in the menopausal transition. All of it shapes what will work best for you. There is no single answer that fits every woman, and a good clinician will not treat you as if there is.
The conversation should cover your personal medical history, including any history of estrogen-sensitive breast cancer, blood clots, active liver disease, or untreated endometrial conditions. It should also cover your family history, your current symptom burden, and whether you have reached menopause or are still in the perimenopausal transition.
A good answer to this question feels like being seen. Your clinician should explain which factors in your profile they have considered, confirm your suitability or discuss any concerns, and tell you clearly how those concerns might be managed if HRT remains an option for you.
Question 2: What Type of HRT Do You Recommend, and Why?
HRT is not a single drug. It is a category that includes estrogen-only therapy, combined estrogen and progestogen therapy, and regimens that also incorporate testosterone. The appropriate type depends principally on whether you have a uterus.
Women who still have a uterus require progestogen alongside estrogen to protect the endometrium from the proliferative effects of unopposed estrogen. Women who have had a hysterectomy can take estrogen alone. Within combined therapy, the type of progestogen matters: body-identical micronised progesterone carries a more favourable safety profile than synthetic progestins, particularly in relation to breast cancer risk.
Ask your clinician to explain not only what they are recommending, but why that formulation fits your specific situation. The answer should be specific to you, not a default.
Question 3: What Route of Delivery Is Right for Me?
This question matters more than it might seem.
HRT can be delivered orally (tablets), transdermally (patches, gels, or sprays), or locally (vaginal creams, pessaries, or rings for urogenital symptoms only). The route of delivery is not just a lifestyle preference. It has real clinical implications, and the right choice for you depends on your health history.
Transdermal estrogen is absorbed directly through the skin and bypasses the liver, which means it does not carry the small increased risk of blood clots and stroke associated with oral estrogen. For women with a personal or family history of thrombosis, or those with cardiovascular risk factors, transdermal delivery is typically preferred.
Local vaginal preparations deliver very low doses of estrogen directly to the vaginal and urethral tissues. They are highly effective for urogenital symptoms such as vaginal dryness, discomfort during intercourse, and recurrent urinary tract infections, without significant systemic absorption. They can often be used alongside systemic HRT or as a standalone option for women whose symptoms are primarily urogenital.
Ask your clinician which route they are recommending and why it is appropriate for your specific health profile and lifestyle.
Question 4: What Benefits Can I Realistically Expect?
Hot Flashes that wake you at 3am. A mood that feels nothing like yours. A brain that will not quite work the way it used to. These are not minor inconveniences. They are symptoms with a clear biological cause, and HRT is the most effective treatment for them available.
The primary purpose of HRT is to relieve vasomotor symptoms such as hot flushes and night sweats, sleep disruption, mood instability, cognitive changes, joint pain, and urogenital changes including vaginal dryness and urinary symptoms.
Beyond symptom relief, HRT offers a range of benefits that extend across long-term health. These include preservation of bone density and reduced fracture risk, cardiovascular protection when initiated within ten years of menopause, a reduced risk of type 2 diabetes, and, in some studies, a reduced risk of Alzheimer’s disease when estrogen is started early in the menopausal transition.
A realistic conversation about benefits should be specific to you. The timeline for symptom improvement varies: vasomotor symptoms often improve within weeks, while other benefits, such as bone protection, accrue over years. Ask your clinician what benefits you can expect to notice, and when.
Question 5: What Are the Risks Most Relevant to My Health History?
This is where the conversation must get personal. The risks of HRT vary considerably depending on the type used, the route of delivery, the dose, your age, how far you are from menopause onset, and your medical history. For most women who are appropriately assessed, the benefits outweigh the risks. But that conclusion only holds when the prescription is genuinely tailored to the individual.
The risks most commonly discussed include a small increased risk of breast cancer with long-term combined HRT use (notably lower with body-identical progesterone than with synthetic progestins), a small increased risk of blood clots with oral estrogen (not associated with transdermal delivery), and modest cardiovascular risk in women who begin HRT more than ten years after menopause onset.
Vague answers are not good enough here. Ask your clinician to tell you what the relevant risks are for you, specifically, based on your health profile. Ask them to express risk in absolute terms, not relative ones. There is a significant difference between a risk that doubles from one in a thousand to two in a thousand, and a risk that doubles from one in ten to two in ten.
Question 6: What Tests or Investigations Do I Need First?
Before you start anything, you deserve a clear picture of where you are. At Menovivre, our Hormone Imbalance and HRT Check programme includes a comprehensive blood panel assessing hormonal profile, thyroid function, metabolic markers, and liver and kidney function, alongside a body composition assessment. This establishes a clear baseline from which the effect of treatment can be measured.
At minimum, before starting HRT, your clinician should assess your blood pressure and body composition, review your cervical screening status, and order hormone and metabolic blood tests. Depending on your history, a pelvic ultrasound, bone density assessment (DEXA scan), or cardiovascular screening may also be appropriate.
Ask your clinician what baseline investigations they intend to conduct, and what information those tests will give both of you before treatment begins.
Question 7: How Will We Monitor Whether It Is Working?
Starting HRT is the beginning of a conversation, not the end of one. Your symptoms, hormone levels, and how you feel will all evolve, and your care should evolve with you. Knowing the monitoring plan before you begin means you are never left wondering whether what you are experiencing is normal, or whether someone is paying attention.
Someone should always be paying attention.
In practical terms, most clinicians schedule a follow-up consultation within eight to twelve weeks of starting HRT to assess symptom response, check for side effects, and review any initial blood results. Thereafter, annual reviews are typical for women on stable regimens, with additional appointments if symptoms change, new concerns arise, or dose adjustment is required.
Ask your clinician what the follow-up schedule looks like, what will be assessed at each review, how you can reach them between appointments if you have concerns, and what parameters they will use to determine whether your current regimen is working optimally.
Question 8: How Long Should I Take HRT, and What Happens If I Stop?
There is no universal answer here. Arbitrary time limits on HRT are not supported by the evidence, and current clinical guidance is clear on this: duration should be decided individually, based on your ongoing symptoms, your health, and what you want.
Some women take HRT for three to five years to manage the acute phase of menopausal symptoms and then stop. Others, particularly those with significant bone density concerns or persistent symptoms, continue for longer. The duration appropriate for you should be discussed, agreed, and reviewed regularly.
The question of stopping is equally important. Menopausal symptoms can return when HRT is discontinued, sometimes acutely. Tapering doses gradually rather than stopping abruptly typically produces fewer rebound symptoms. Ask your clinician how and when they would suggest reviewing the decision to continue or stop, and what that process would look like.
Finding the Right Clinician for This Conversation
You should not have to fight to be heard.
The decision about whether HRT is right for you should be made together, with someone who has listened properly, considered your full history, and explained your options clearly. If that is not the conversation you have had so far, you are allowed to seek a different one.
At Menovivre, you will not be rushed and you will not be dismissed. Bring your questions. Bring your uncertainty. Bring the symptoms you have been managing quietly and the ones you have not known how to name. You can request an appointment without a GP referral. We will take it from there, together.
Frequently Asked Questions
Q1: Is HRT safe?
Q2. I am perimenopausal, not postmenopausal. Can I start HRT?
Q3. What is the difference between HRT and BHRT?
Q4. Will HRT cause weight gain?
Q5. Do I need a referral to see a Menovivre clinician?
Q6. How quickly does HRT start working?
Q7. Can I take HRT if I have a family history of breast cancer?
Q8. What should I bring to my HRT consultation?
